FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Antimicrob Agents Chemother / Imidocarb dipropionate clears persistent Babesia caballi inf...
Antimicrobial agents and chemotherapy2009; 53(10); 4327-4332; doi: 10.1128/AAC.00404-09

Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential.

Abstract: Antimicrobial treatment of persistent infection to eliminate transmission risk represents a specific challenge requiring compelling evidence of complete pathogen clearance. The limited repertoire of antimicrobial agents targeted at protozoal parasites magnifies this challenge. Using Babesia caballi as both a model and a specific apicomplexan pathogen for which evidence of the elimination of transmission risk is required for international animal movement, we tested whether a high-dose regimen of imidocarb dipropionate cleared infection from persistently infected asymptomatic horses and/or eliminated transmission risk. Clearance with elimination of transmission risk was supported by the following four specific lines of evidence: (i) inability to detect parasites by quantitative PCR and nested PCR amplification, (ii) conversion from seropositive to seronegative status, (iii) inability to transmit infection by direct inoculation of blood into susceptible recipient horses, and (iv) inability to transmit infection by ticks acquisition fed on the treated horses and subsequently transmission fed on susceptible horses. In contrast, untreated horses remained infected and capable of transmitting B. caballi using the same criteria. These findings establish that imidocarb dipropionate treatment clears B. caballi infection with confirmation of lack of transmission risk either by direct blood transfer or a high tick burden. Importantly, the treated horses revert to seronegative status according to the international standard for serologic testing and would be permitted to move between countries where the pathogen is endemic and countries that are free of the pathogen.
Get Full Text
Publication Date: 2009-07-20 PubMed ID: 19620328PubMed Central: PMC2764191DOI: 10.1128/AAC.00404-09Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research studied whether a highly dosed treatment of imidocarb dipropionate would clear Babesia caballi infection in persistently infected horses and if it would prevent further transmission. Results indicated the treatment was successful in eradicating the infection and preventing transmission through both direct blood transfer and ticks.

Overview of Research

  • The study was focused on whether a high-dose regimen of a drug called imidocarb dipropionate could clear Babesia caballi infection in horses that are persistently infected.
  • Besides clearing the infection, the researchers were interested in seeing if the drug could also eliminate the risk of the infection spreading.
  • Due to its application in international animal movement, the research also holds value in assessing evidence required for the elimination of transmission risk of this particular parasite.

Methodology and Evidence

  • The effects of the drug were evaluated by four main evidentiary points: first, the inability to detect parasites post-treatment; second, the conversion of seropositive status to seronegative; third, the inability to transfer the infection to other horses via direct blood transfer; and fourth, the inability of ticks which were fed on the treated horses to transfer the infection.
  • The study also included a control group of untreated horses who remained infected and capable of transmitting B. caballi.

Findings and Implications

  • The findings indicated that imidocarb dipropionate was indeed successful in clearing the infection in horses and removing the risk of transmission. Treated horses also reverted to a seronegative status, thus meeting the international standard for serologic testing.
  • These findings hold implications for international horse trading and movement. Treated horses could consequently be permitted to move between countries where the parasite is endemic and countries free of the infection safely without transmission risk.

Cite This Article

APA
Schwint ON, Ueti MW, Palmer GH, Kappmeyer LS, Hines MT, Cordes RT, Knowles DP, Scoles GA. (2009). Imidocarb dipropionate clears persistent Babesia caballi infection with elimination of transmission potential. Antimicrob Agents Chemother, 53(10), 4327-4332. https://doi.org/10.1128/AAC.00404-09

Publication

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
NlmUniqueID: 0315061
Country: United States
Language: English
Volume: 53
Issue: 10
Pages: 4327-4332

Researcher Affiliations

Schwint, O Nicolas
  • Program in Vector-Borne Diseases, Department of Veterinary Microbiology and Pathology, School for Global Animal Heath, Washington State University, Pullman, WA 99164-7040, USA.
Ueti, Massaro W
    Palmer, Guy H
      Kappmeyer, Lowell S
        Hines, Melissa T
          Cordes, R Timothy
            Knowles, Donald P
              Scoles, Glen A

                MeSH Terms

                • Animals
                • Anti-Infective Agents / therapeutic use
                • Babesia / drug effects
                • Babesia / pathogenicity
                • Babesiosis / drug therapy
                • Babesiosis / microbiology
                • Babesiosis / transmission
                • Disease Transmission, Infectious / prevention & control
                • Horses
                • Imidocarb / analogs & derivatives
                • Imidocarb / therapeutic use
                • Ticks / microbiology

                Grant Funding

                • T32 AI007025 / NIAID NIH HHS

                References

                This article includes 30 references
                1. Adams LG. Clinicopathological aspects of imidocarb dipropionate toxicity in horses.. Res Vet Sci 1981 Jul;31(1):54-61.
                  pubmed: 7313320
                2. Allred DR, Al-Khedery B. Antigenic variation and cytoadhesion in Babesia bovis and Plasmodium falciparum: different logics achieve the same goal.. Mol Biochem Parasitol 2004 Mar;134(1):27-35.
                  pubmed: 14747140doi: 10.1016/j.molbiopara.2003.09.012google scholar: lookup
                3. Böse R, Daemen K. Demonstration of the humoral immune response of horses to Babesia caballi by western blotting.. Int J Parasitol 1992 Aug;22(5):627-30.
                  pubmed: 1399247doi: 10.1016/0020-7519(92)90011-9google scholar: lookup
                4. Brayton KA, Lau AO, Herndon DR, Hannick L, Kappmeyer LS, Berens SJ, Bidwell SL, Brown WC, Crabtree J, Fadrosh D, Feldblum T, Forberger HA, Haas BJ, Howell JM, Khouri H, Koo H, Mann DJ, Norimine J, Paulsen IT, Radune D, Ren Q, Smith RK Jr, Suarez CE, White O, Wortman JR, Knowles DP Jr, McElwain TF, Nene VM. Genome sequence of Babesia bovis and comparative analysis of apicomplexan hemoprotozoa.. PLoS Pathog 2007 Oct 19;3(10):1401-13.
                  pmc: PMC2034396pubmed: 17953480doi: 10.1371/journal.ppat.0030148google scholar: lookup
                5. Brüning A. Equine piroplasmosis an update on diagnosis, treatment and prevention.. Br Vet J 1996 Mar;152(2):139-51.
                  pubmed: 8680838doi: 10.1016/s0007-1935(96)80070-4google scholar: lookup
                6. Butler CM, Nijhof AM, van der Kolk JH, de Haseth OB, Taoufik A, Jongejan F, Houwers DJ. Repeated high dose imidocarb dipropionate treatment did not eliminate Babesia caballi from naturally infected horses as determined by PCR-reverse line blot hybridization.. Vet Parasitol 2008 Feb 14;151(2-4):320-2.
                  pubmed: 18160222doi: 10.1016/j.vetpar.2007.11.010google scholar: lookup
                7. Carbrey EA, Avery RJ, Knowles RC, Sash SC. Chemotherapy of equine babesiosis.. J Am Vet Med Assoc 1971 Dec 1;159(11):1538-45.
                  pubmed: 5005185
                8. Delany-Moretlwe S, Lingappa JR, Celum C. New insights on interactions between HIV-1 and HSV-2.. Curr Infect Dis Rep 2009 Mar;11(2):135-42.
                  pubmed: 19239804doi: 10.1007/s11908-009-0020-8google scholar: lookup
                9. de Waal DT. Equine piroplasmosis: a review.. Br Vet J 1992 Jan-Feb;148(1):6-14.
                  pubmed: 1551016doi: 10.1016/0007-1935(92)90061-5google scholar: lookup
                10. Dolan TT. Chemotherapy of East Coast fever: the long term weight changes, carrier state and disease manifestations of parvaquone treated cattle.. J Comp Pathol 1986 Mar;96(2):137-46.
                  pubmed: 3084600doi: 10.1016/0021-9975(86)90004-6google scholar: lookup
                11. Ewing SA, Panciera RJ, Mathew JS. Persistence of Hepatozoon americanum (Apicomplexa: Adeleorina) in a naturally infected dog.. J Parasitol 2003 Jun;89(3):611-3.
                  pubmed: 12880267doi: 10.1645/GE-3138RNgoogle scholar: lookup
                12. Frerichs WM, Holbrook AA. Treatment of equine piroplasmosis (B caballi) with imidocarb dipropionate.. Vet Rec 1974 Aug 31;95(9):188-9.
                  pubmed: 4450446doi: 10.1136/vr.95.9.188google scholar: lookup
                13. Frerichs WM, Holbrook AA, Johnson AJ. Equine piroplasmosis: complement-fixation titers of horses infected with Babesia caballi.. Am J Vet Res 1969 May;30(5):697-702.
                  pubmed: 5813666
                14. Friedhoff KT, Tenter AM, Müller I. Haemoparasites of equines: impact on international trade of horses.. Rev Sci Tech 1990 Dec;9(4):1187-94.
                  pubmed: 2132711
                15. Futse JE, Brayton KA, Knowles DP Jr, Palmer GH. Structural basis for segmental gene conversion in generation of Anaplasma marginale outer membrane protein variants.. Mol Microbiol 2005 Jul;57(1):212-21.
                  pubmed: 15948961doi: 10.1111/j.1365-2958.2005.04670.xgoogle scholar: lookup
                16. Goff WL, O'Rourke KI, Johnson WC, Lacy PA, Davis WC, Wyatt CR. The role of IL-10 in iNOS and cytokine mRNA expression during in vitro differentiation of bovine mononuclear phagocytes.. J Interferon Cytokine Res 1998 Mar;18(3):139-49.
                  pubmed: 9555975doi: 10.1089/jir.1998.18.139google scholar: lookup
                17. Hodzic E, Feng S, Holden K, Freet KJ, Barthold SW. Persistence of Borrelia burgdorferi following antibiotic treatment in mice.. Antimicrob Agents Chemother 2008 May;52(5):1728-36.
                  pmc: PMC2346637pubmed: 18316520doi: 10.1128/AAC.01050-07google scholar: lookup
                18. Holman PJ, Frerichs WM, Chieves L, Wagner GG. Culture confirmation of the carrier status of Babesia caballi-infected horses.. J Clin Microbiol 1993 Mar;31(3):698-701.
                  pmc: PMC262846pubmed: 8458966doi: 10.1128/jcm.31.3.698-701.1993google scholar: lookup
                19. Howell JM, Ueti MW, Palmer GH, Scoles GA, Knowles DP. Persistently infected calves as reservoirs for acquisition and transovarial transmission of Babesia bovis by Rhipicephalus (Boophilus) microplus.. J Clin Microbiol 2007 Oct;45(10):3155-9.
                  pmc: PMC2045367pubmed: 17687016doi: 10.1128/JCM.00766-07google scholar: lookup
                20. Kappmeyer LS, Perryman LE, Hines SA, Baszler TV, Katz JB, Hennager SG, Knowles DP. Detection of equine antibodies to babesia caballi by recombinant B. caballi rhoptry-associated protein 1 in a competitive-inhibition enzyme-linked immunosorbent assay.. J Clin Microbiol 1999 Jul;37(7):2285-90.
                  pmc: PMC85139pubmed: 10364599doi: 10.1128/JCM.37.7.2285-2290.1999google scholar: lookup
                21. Knowles DP Jr. Control of Babesia equi parasitemia.. Parasitol Today 1996 May;12(5):195-8.
                  pubmed: 15275213doi: 10.1016/0169-4758(96)10007-7google scholar: lookup
                22. Knowles DP Jr, Kappmeyer LS, Stiller D, Hennager SG, Perryman LE. Antibody to a recombinant merozoite protein epitope identifies horses infected with Babesia equi.. J Clin Microbiol 1992 Dec;30(12):3122-6.
                  pmc: PMC270599pubmed: 1280648doi: 10.1128/jcm.30.12.3122-3126.1992google scholar: lookup
                23. Krause PJ, Gewurz BE, Hill D, Marty FM, Vannier E, Foppa IM, Furman RR, Neuhaus E, Skowron G, Gupta S, McCalla C, Pesanti EL, Young M, Heiman D, Hsue G, Gelfand JA, Wormser GP, Dickason J, Bia FJ, Hartman B, Telford SR 3rd, Christianson D, Dardick K, Coleman M, Girotto JE, Spielman A. Persistent and relapsing babesiosis in immunocompromised patients.. Clin Infect Dis 2008 Feb 1;46(3):370-6.
                  pubmed: 18181735doi: 10.1086/525852google scholar: lookup
                24. Krause PJ, Spielman A, Telford SR 3rd, Sikand VK, McKay K, Christianson D, Pollack RJ, Brassard P, Magera J, Ryan R, Persing DH. Persistent parasitemia after acute babesiosis.. N Engl J Med 1998 Jul 16;339(3):160-5.
                  pubmed: 9664092doi: 10.1056/NEJM199807163390304google scholar: lookup
                25. Menge DM, Ernst KC, Vulule JM, Zimmerman PA, Guo H, John CC. Microscopy underestimates the frequency of Plasmodium falciparum infection in symptomatic individuals in a low transmission highland area.. Am J Trop Med Hyg 2008 Aug;79(2):173-7.
                  pmc: PMC2590590pubmed: 18689620
                26. Schwint ON, Knowles DP, Ueti MW, Kappmeyer LS, Scoles GA. Transmission of Babesia caballi by Dermacentor nitens (Acari: Ixodidae) is restricted to one generation in the absence of alimentary reinfection on a susceptible equine host.. J Med Entomol 2008 Nov;45(6):1152-5.
                  pubmed: 19058641doi: 10.1603/0022-2585(2008)45[1152:tobcbd]2.0.co;2google scholar: lookup
                27. Thompson KC, Todorovic RA, Mateus G, Adams LG. Methods to improve the health of cattle in the tropics: conclusions and economic appraisal.. Trop Anim Health Prod 1978 Aug;10(3):141-4.
                  pubmed: 705891doi: 10.1007/BF02235326google scholar: lookup
                28. Ueti MW, Palmer GH, Scoles GA, Kappmeyer LS, Knowles DP. Persistently infected horses are reservoirs for intrastadial tick-borne transmission of the apicomplexan parasite Babesia equi.. Infect Immun 2008 Aug;76(8):3525-9.
                  pmc: PMC2493223pubmed: 18490466doi: 10.1128/IAI.00251-08google scholar: lookup
                29. Vial HJ, Gorenflot A. Chemotherapy against babesiosis.. Vet Parasitol 2006 May 31;138(1-2):147-60.
                  pubmed: 16504402doi: 10.1016/j.vetpar.2006.01.048google scholar: lookup
                30. Wilson WD, Mihalyi JE, Hussey S, Lunn DP. Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination.. Equine Vet J 2001 Nov;33(7):644-50.
                  pubmed: 11770984doi: 10.2746/042516401776249435google scholar: lookup

                Citations

                This article has been cited 14 times.
                1. Graham H, van Kalsbeek P, van der Goot J, Koene MGJ. Low seroprevalence of equine piroplasmosis in horses exported from the Netherlands between 2015 and 2021.. Front Vet Sci 2022;9:954046.
                  doi: 10.3389/fvets.2022.954046pubmed: 36299627google scholar: lookup
                2. Salinas-Estrella E, Ueti MW, Lobanov VA, Castillo-Payró E, Lizcano-Mata A, Badilla C, Martínez-Ibáñez F, Mosqueda J. Serological and molecular detection of Babesia caballi and Theileria equi in Mexico: A prospective study.. PLoS One 2022;17(3):e0264998.
                  doi: 10.1371/journal.pone.0264998pubmed: 35259206google scholar: lookup
                3. Nadal C, Marsot M, Le Metayer G, Boireau P, Guillot J, Bonnet SI. Spatial and Temporal Circulation of Babesia caballi and Theileria equi in France Based on Seven Years of Serological Data.. Pathogens 2022 Feb 9;11(2).
                  doi: 10.3390/pathogens11020227pubmed: 35215171google scholar: lookup
                4. Yang G, Chen K, Guo W, Hu Z, Qi T, Liu D, Wang Y, Du C, Wang X. Development of a Test Card Based on Colloidal Gold Immunochromatographic Strips for Rapid Detection of Antibodies against Theileria equi and Babesia caballi.. Microbiol Spectr 2022 Feb 23;10(1):e0241121.
                  doi: 10.1128/spectrum.02411-21pubmed: 35196786google scholar: lookup
                5. Tirosh-Levy S, Gottlieb Y, Fry LM, Knowles DP, Steinman A. Twenty Years of Equine Piroplasmosis Research: Global Distribution, Molecular Diagnosis, and Phylogeny.. Pathogens 2020 Nov 8;9(11).
                  doi: 10.3390/pathogens9110926pubmed: 33171698google scholar: lookup
                6. Guo J, Luo X, Wang S, He L, Zhao J. Xanthohumol and Gossypol Are Promising Inhibitors against Babesia microti by In Vitro Culture via High-Throughput Screening of 133 Natural Products.. Vaccines (Basel) 2020 Oct 16;8(4).
                  doi: 10.3390/vaccines8040613pubmed: 33081295google scholar: lookup
                7. Mshelia PW, Kappmeyer L, Johnson WC, Kudi CA, Oluyinka OO, Balogun EO, Richard EE, Onoja E, Sears KP, Ueti MW. Molecular detection of Theileria species and Babesia caballi from horses in Nigeria.. Parasitol Res 2020 Sep;119(9):2955-2963.
                  doi: 10.1007/s00436-020-06797-ypubmed: 32647992google scholar: lookup
                8. Lobanov VA, Peckle M, Massard CL, Brad Scandrett W, Gajadhar AA. Development and validation of a duplex real-time PCR assay for the diagnosis of equine piroplasmosis.. Parasit Vectors 2018 Mar 2;11(1):125.
                  doi: 10.1186/s13071-018-2751-6pubmed: 29499748google scholar: lookup
                9. Guidi E, Pradier S, Lebert I, Leblond A. Piroplasmosis in an endemic area: analysis of the risk factors and their implications in the control of Theileriosis and Babesiosis in horses.. Parasitol Res 2015 Jan;114(1):71-83.
                  doi: 10.1007/s00436-014-4161-9pubmed: 25280516google scholar: lookup
                10. Yabsley MJ, Shock BC. Natural history of Zoonotic Babesia: Role of wildlife reservoirs.. Int J Parasitol Parasites Wildl 2013 Dec;2:18-31.
                  doi: 10.1016/j.ijppaw.2012.11.003pubmed: 24533312google scholar: lookup
                11. Awinda PO, Mealey RH, Williams LB, Conrad PA, Packham AE, Reif KE, Grause JF, Pelzel-McCluskey AM, Chung C, Bastos RG, Kappmeyer LS, Howe DK, Ness SL, Knowles DP, Ueti MW. Serum antibodies from a subset of horses positive for Babesia caballi by competitive enzyme-linked immunosorbent assay demonstrate a protein recognition pattern that is not consistent with infection.. Clin Vaccine Immunol 2013 Nov;20(11):1752-7.
                  doi: 10.1128/CVI.00479-13pubmed: 24049108google scholar: lookup
                12. Bastos RG, Suarez CE, Laughery JM, Johnson WC, Ueti MW, Knowles DP. Differential expression of three members of the multidomain adhesion CCp family in Babesia bigemina, Babesia bovis and Theileria equi.. PLoS One 2013;8(7):e67765.
                  doi: 10.1371/journal.pone.0067765pubmed: 23844089google scholar: lookup
                13. Ueti MW, Mealey RH, Kappmeyer LS, White SN, Kumpula-McWhirter N, Pelzel AM, Grause JF, Bunn TO, Schwartz A, Traub-Dargatz JL, Hendrickson A, Espy B, Guthrie AJ, Fowler WK, Knowles DP. Re-emergence of the apicomplexan Theileria equi in the United States: elimination of persistent infection and transmission risk.. PLoS One 2012;7(9):e44713.
                  doi: 10.1371/journal.pone.0044713pubmed: 22970295google scholar: lookup
                14. Barratt JL, Harkness J, Marriott D, Ellis JT, Stark D. Importance of nonenteric protozoan infections in immunocompromised people.. Clin Microbiol Rev 2010 Oct;23(4):795-836.
                  doi: 10.1128/CMR.00001-10pubmed: 20930074google scholar: lookup
                Subscribe to our newsletter
                Join 99,359 horse owners like you who receive our email updates on horse health and nutrition.